Professor of Pediatrics
Mayo Clinic College of Medicine and Science
W. Charles Huskins, MD, MSc is a Professor of Pediatrics at the Mayo Clinic College of Medicine and Science, the Chair of the Division of Pediatric Infectious Diseases at Mayo Clinic, and the Healthcare Epidemiologist and Vice Chair for Quality in the Mayo Clinic Children’s Center.
He received his MD from the University of Minnesota Medical School and his MSc in Epidemiology from the Harvard School of Public Health. He completed his pediatrics and pediatric infectious diseases training at Boston Children’s Hospital.
Dr. Huskins previously served as a member of the Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee, the Clinical Quality Improvement Subcommittee for the Children’s Hospital Association, and the Pediatric Special Interest Group for the National Institute for Allergy and Infectious Diseases (NIAID) funded Antibacterial Resistance Leadership Group (ARLG). He currently serves on the Nominations Committee for the Pediatric Infectious Diseases Society and the Steering Committee for the Children’s Hospital Association’s Improving Pediatric Sepsis Outcomes collaborative.
He is a Fellow of the Infectious Diseases Society of America, the Society of Healthcare Epidemiology of America, and the Pediatric Infectious Diseases Society. He serves on the Editorial Board for the Journal of the Pediatric Infectious Diseases Society and Pediatric Quality and Safety.
Dr. Huskins is the ARLG study co-principal investigator for the NIAID-funded “A Phase IV Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate Short Course vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children” (SCOUT-CAP, DMID Protocol 14-0079).
Dr. Huskins is the author of over 80 peer-reviewed publications in the fields of pediatric infectious diseases, healthcare acquired infection, antimicrobial resistance, antimicrobial stewardship, patient safety and quality improvement.
Disclosure: ADMA Biologics (Individual(s) Involved: Self): Consultant; Pfizer, Inc (Individual(s) Involved: Self): Consultant
